TUCKER CARLSON (HOST): Well, the massive disruption everyone in the country is enduring at the moment isn't just meant to give our hospitals time to prepare. It's also buying us time to figure out how to treat the coronavirus. This is a country of science and we will defeat this at some point, the sooner the better.
Fortunately, there's some good news to report tonight on that front. Early evidence suggests that chloroquine -- that's a cheap antimalaria drug -- may be effective in treating coronavirus. Gregory Rigano is an adviser at the Stanford University School of Medicine, and he joins us tonight. Mr. Rigano, thanks so much for coming on. So tell us what this is and why you think it's promising, please?
GREGORY RIGANO: So the president has the authority to authorize the use of hydroxychloroquine against coronavirus immediately. He has cut more red tape at the FDA than any other president in history. And for example, in 2017, a new drug was approved for muscular dystrophy that in a clinical trial [inaudible] -- for a clinical trial that enrolled less than 15 patients, and it was generally uncontrolled in an open setting.
Hydroxychloroquine has been on the market for over 50 years with a quality safety profile, and I'm here to report that as of this morning, about 5 o'clock this morning, a well-controlled, peer-reviewed study carried out by the most eminent infectious disease specialist in the world, Didier Raoult, MD, PhD, out of the south of France, in which he enrolled 40 patients -- again, a well-controlled, peer-reviewed study that showed a 100% cure rate against coronavirus. The study was released this morning on my Twitter account, RiganoESQ, as well as our most recent website, covidtrial.io. The study was recently accepted to the International Journal of Antimicrobial Agents by Elsevier.
CARLSON: So obviously, I only know what you're telling me, but I do know it's very unusual for a study of anything to produce results of a hundred percent. I mean that's remarkable, isn't it? Or am I missing something?
RIGANO: That is remarkable. In fact, to be able to cure a virus was said to be mathematically impossible and the first company that did it was a small biotech called Pharmasset that was acquired by Gilead Sciences in the cure to hepatitis C. What we're here to announce is the second cure to a virus of all time.
CARLSON: Well, that's -- I mean, remarkable. I mean, of course, it's our job to be skeptical of all and any claims. However, I very much want to believe this, and I think we need obviously immediately to run it down. The federal government needs to find out if this is true, because if it is, you know, that's the biggest news of this moment. So I'm so grateful that you announced that on the show, and I hope we're hearing a lot more about it very soon. Thank you so much for coming on.